Examkin

Question

Difficulty: MediumMonitoring and Treatment Evaluation

A 71-year-old man presents to the outpatient clinic for a follow-up appointment four weeks following a hospitalization for new-onset atrial fibrillation. While admitted, oral amiodarone was initiated for maintenance of sinus rhythm. The patient reports feeling well with no palpitations, dyspnea, or chest pain. His current medications include amiodarone, lisinopril, and atorvastatin. Today's electrocardiogram demonstrates normal sinus rhythm with a heart rate of 68/min and a QTc interval of 430 ms. The physician counsels the patient on the necessity of longitudinal follow-up to detect potential medication-induced toxicities. Which of the following evaluations are required as part of routine periodic monitoring for this patient's antiarrhythmic therapy? (Select all that apply)

  1. Serum thyroid-stimulating hormone levelAnswer
  2. Serum alanine aminotransferase levelAnswer
  3. ElectrocardiogramAnswer
  4. D
    High-resolution computed tomography of the chest
  5. E
    Serum creatine kinase level

Answer

The necessary routine monitoring parameters for a patient on long-term amiodarone therapy include a serum thyroid-stimulating hormone level, a serum alanine aminotransferase level, and an electrocardiogram.
Amiodarone is a highly effective antiarrhythmic agent but carries a significant risk of multiorgan toxicity. Routine periodic monitoring is strictly required to detect insidious adverse effects early. Its high iodine content and direct cytotoxic effects can cause both hypothyroidism and hyperthyroidism, necessitating regular monitoring of serum thyroid-stimulating hormone. It can also cause asymptomatic hepatotoxicity, making periodic assessment of serum alanine aminotransferase essential. Finally, as a class III antiarrhythmic, amiodarone prolongs the action potential and can cause dangerous QTc prolongation or bradycardia, requiring routine electrocardiographic surveillance.

Step-by-Step Solution

1
Identify the primary medication and its multiorgan toxicity profile.
The patient is taking amiodarone, a class III antiarrhythmic known to cause thyroid, hepatic, pulmonary, and cardiac toxicities.
Understanding the unique adverse effects of a high-risk pharmacotherapy is required to establish the correct surveillance strategy.
2
Determine the guideline-concordant routine screening tests for amiodarone.
Routine periodic monitoring mandates a serum TSH, liver function tests (including ALT), and an electrocardiogram.
These specific tests detect the most common and dangerous insidious toxicities of amiodarone before they become clinically severe.
3
Evaluate the remaining options against appropriate utilization standards.
High-resolution computed tomography of the chest and routine serum creatine kinase levels are excluded.
Routine HRCT is an overutilization of advanced imaging when a standard chest radiograph suffices. Routine CK monitoring is inappropriate for asymptomatic patients on statins, despite the presence of a CYP3A4 interaction with amiodarone.

Key Concept

Patients receiving long-term amiodarone therapy require routine periodic monitoring of thyroid function (TSH), liver function (AST/ALT), and cardiac conduction (ECG) to detect potentially severe adverse effects.
Rate this question

Topics

Monitoring and Treatment Evaluation

More questions from this topic